BioCentury
ARTICLE | Clinical News

Neurobloc botulinum toxin type B: Phase III completed

April 27, 1998 7:00 AM UTC

ELN announced Phase III data in about 200 patients with cervical dystonia, with each of two trials achieving statistical significance for the end point of clinical improvement. Patients received a sin...